These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22297671)

  • 1. The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers.
    Cameron M; Maalouf NM; Poindexter J; Adams-Huet B; Sakhaee K; Moe OW
    Kidney Int; 2012 Jun; 81(11):1123-30. PubMed ID: 22297671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
    Sakhaee K; Adams-Huet B; Moe OW; Pak CY
    Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers.
    Singh RK; Bansal A
    Prog Clin Biol Res; 1987; 227B():305-13. PubMed ID: 3628342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone.
    Maalouf NM; Poindexter JR; Adams-Huet B; Moe OW; Sakhaee K
    Kidney Int; 2019 May; 95(5):1262-1268. PubMed ID: 30795852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.
    Doizi S; Rodgers K; Poindexter J; Sakhaee K; Maalouf NM
    J Urol; 2016 Jun; 195(6):1799-804. PubMed ID: 26723865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis.
    Bobulescu IA; Park SK; Xu LHR; Blanco F; Poindexter J; Adams-Huet B; Davidson TL; Sakhaee K; Maalouf NM; Moe OW
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):411-420. PubMed ID: 30745301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
    Abate N; Chandalia M; Cabo-Chan AV; Moe OW; Sakhaee K
    Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and dietary factors of uric acid stone formation.
    Trinchieri A; Montanari E
    Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Changes in Kidney Stone Composition and in Risk Factors Predisposing to Stone Formation.
    Xu LHR; Adams-Huet B; Poindexter JR; Maalouf NM; Moe OW; Sakhaee K
    J Urol; 2017 Jun; 197(6):1465-1471. PubMed ID: 28111301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The loss of circadian rhythmicity of urinary solute excretion in idiopathic stone formers.
    Sidhu H; Vaidyanathan S; Wangoo D; Thind SK; Nath R; Malakondaiah GC; Krishan K
    Br J Urol; 1989 Oct; 64(4):333-5. PubMed ID: 2819381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms for falling urine pH with age in stone formers.
    Menezes CJ; Worcester EM; Coe FL; Asplin J; Bergsland KJ; Ko B
    Am J Physiol Renal Physiol; 2019 Jul; 317(7):F65-F72. PubMed ID: 31017011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid saturation in calcium nephrolithiasis.
    Coe FL; Strauss AL; Tembe V; Le Dun S
    Kidney Int; 1980 May; 17(5):662-8. PubMed ID: 7401461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for disordered acid-base handling in calcium stone-forming patients.
    Worcester EM; Bergsland KJ; Gillen DL; Coe FL
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F363-F374. PubMed ID: 31790303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.